Agilent Technologies (NYSE:A) Updates FY 2025 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 5.540-5.610 for the period, compared to the consensus estimate of 5.660. The company issued revenue guidance of $6.8 billion-$6.9 billion, compared to the consensus revenue estimate of $6.8 billion. Agilent Technologies also updated its FY25 guidance to $5.54-5.61 EPS.

Agilent Technologies Price Performance

A opened at $138.11 on Thursday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. The stock has a market capitalization of $39.68 billion, a P/E ratio of 28.65, a P/E/G ratio of 5.91 and a beta of 1.07. The company’s 50-day simple moving average is $137.72 and its two-hundred day simple moving average is $137.43. Agilent Technologies has a 52-week low of $124.10 and a 52-week high of $155.35.

Agilent Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.248 per share. The ex-dividend date is Tuesday, December 31st. This represents a $0.99 annualized dividend and a yield of 0.72%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio is currently 20.54%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Barclays lowered their price objective on shares of Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a research note on Wednesday. TD Cowen raised their target price on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Bank of America increased their price objective on shares of Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. JPMorgan Chase & Co. cut their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday. Finally, Evercore ISI increased their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, seven have given a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $143.40.

Insiders Place Their Bets

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is owned by insiders.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.